Total Payments
$125,152
2024 Payments
$817.91
Companies
35
Transactions
577
Medicare Patients
649
Medicare Billing
$219,717
Payment Breakdown by Category
Other$84,650 (67.6%)
Travel$26,277 (21.0%)
Food & Beverage$13,932 (11.1%)
Education$292.45 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $64,150 | 32 | 51.3% |
| Travel and Lodging | $26,277 | 76 | 21.0% |
| Honoraria | $20,500 | 11 | 16.4% |
| Food and Beverage | $13,932 | 443 | 11.1% |
| Education | $292.45 | 15 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $108,775 | 233 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,243 | 49 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $3,634 | 20 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,529 | 52 | $0 (2024) |
| Amgen Inc. | $1,294 | 48 | $0 (2023) |
| Relypsa, Inc. | $878.03 | 35 | $0 (2020) |
| Mallinckrodt Hospital Products Inc. | $552.05 | 19 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $522.01 | 22 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $507.05 | 14 | $0 (2024) |
| Travere Therapeutics, Inc. | $455.16 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $817.91 | 23 | Otsuka America Pharmaceutical, Inc. ($211.64) |
| 2023 | $10,769 | 65 | Fresenius USA Marketing, Inc. ($8,991) |
| 2022 | $17,233 | 91 | Fresenius USA Marketing, Inc. ($14,729) |
| 2021 | $6,218 | 57 | Aurinia Pharma U.S., Inc. ($2,625) |
| 2020 | $3,263 | 31 | AstraZeneca Pharmaceuticals LP ($2,807) |
| 2019 | $2,775 | 79 | Fresenius USA Marketing, Inc. ($1,416) |
| 2018 | $29,611 | 110 | Fresenius USA Marketing, Inc. ($28,282) |
| 2017 | $54,465 | 121 | Fresenius USA Marketing, Inc. ($52,964) |
All Payment Transactions
577 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/31/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/20/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/15/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/03/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $30.04 | General |
| 05/03/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 04/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: NEPHROLOGY | ||||||
| 04/24/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/17/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: NEPHROLOGY | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.51 | General |
| 04/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: IMMUNOLOGY | ||||||
| 03/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.11 | General |
| Category: Cardio-renal | ||||||
| 03/06/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: NEPHROLOGY | ||||||
| 03/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Cardio-renal | ||||||
| 03/01/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/20/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $118.76 | General |
| Category: NEPHROLOGY | ||||||
| 02/05/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEPHROLOGY | ||||||
| 02/02/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/29/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 01/24/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $104.24 | General |
| Category: NEPHROLOGY | ||||||
| 01/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/15/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $33.06 | General |
| 12/15/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 125 | 176 | $37,801 | $14,327 |
| 2022 | 3 | 146 | 276 | $84,202 | $32,748 |
| 2021 | 6 | 189 | 480 | $201,563 | $76,859 |
| 2020 | 6 | 189 | 657 | $303,029 | $95,783 |
Total Patients
649
Total Services
1,589
Medicare Billing
$219,717
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 83 | $18,094 | $7,551 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 81 | $13,851 | $4,837 | 34.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,856 | $1,939 | 33.1% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 11 | 81 | $46,251 | $18,167 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 98 | $21,364 | $8,705 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 97 | $16,587 | $5,876 | 35.4% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 14 | 138 | $78,798 | $30,209 | 38.3% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 17 | 98 | $56,056 | $22,010 | 39.3% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 17 | 56 | $24,696 | $8,589 | 34.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 75 | $16,350 | $7,140 | 43.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 93 | $15,903 | $5,660 | 35.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 20 | 20 | $9,760 | $3,250 | 33.3% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 34 | 220 | $125,840 | $40,486 | 32.2% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2020 | 17 | 166 | $94,786 | $30,420 | 32.1% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2020 | 28 | 118 | $52,038 | $16,683 | 32.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 77 | 107 | $18,297 | $4,426 | 24.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 34 | $7,412 | $2,467 | 33.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $4,656 | $1,302 | 28.0% |
About Dr. Marc Stegman, M.D
Dr. Marc Stegman, M.D is a Specialist healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023019825.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Stegman, M.D has received a total of $125,152 in payments from pharmaceutical and medical device companies, with $817.91 received in 2024. These payments were reported across 577 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($64,150).
As a Medicare-enrolled provider, Stegman has provided services to 649 Medicare beneficiaries, totaling 1,589 services with total Medicare billing of $219,717. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Memphis, TN
- Active Since 08/03/2005
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1023019825
Products in Payments
- Velphoro (Drug) $105,218
- LOKELMA (Drug) $3,788
- Not Product Related (Medical Supply) $3,315
- LUPKYNIS (Drug) $3,134
- JYNARQUE (Drug) $1,485
- ACTHAR (Biological) $1,074
- Veltassa (Drug) $892.65
- Parsabiv (Biological) $869.48
- Kerendia (Drug) $507.05
- FARXIGA (Drug) $454.50
- KRYSTEXXA (Biological) $258.11
- ZEPATIER (Drug) $237.67
- XPHOZAH 30 MG (Drug) $217.08
- Parsabiv (Drug) $201.41
- TAVNEOS (Drug) $187.97
- TARPEYO (Drug) $152.09
- BENLYSTA (Biological) $142.32
- IBSRELA (Drug) $125.07
- NEXLETOL (Drug) $119.28
- INVOKANA (Drug) $118.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Memphis
Dr. Ramesh Gupta, M.d, M.D
Specialist — Payments: $1.9M
Specialist $1.9M
Andrei Alexandrov, Md, MD
Specialist — Payments: $287,325
Specialist $287,325
Dr. Richard Fine, M.d, M.D
Specialist — Payments: $23,144
Specialist $23,144
Mrs. Lanetta Anderson, Md, MD
Specialist — Payments: $11,242
Specialist $11,242
Dr. Sudha Ganguli, M.d, M.D
Specialist — Payments: $9,194
Specialist $9,194
Dr. Robert Wegner, M.d, M.D
Specialist — Payments: $9,060
Specialist $9,060